Paul Hastings LLP advised Xoma Corporation on the deal.Xoma Corporation, a biotechnology and pharmaceutical royalty aggregator announced its multi-license and milestone monetization transaction with Viracta Therapeutics. Under…
XOMA and Viracta Therapeutics’ Multi-License Milestone and Royalty Monetization Transaction
